Alkermes (ALKS) CEO Jackson Curtis Receives Equity Award

What Happened
Jackson Blair Curtis, President and Chief Executive Officer of Alkermes plc (ALKS), was granted two equity awards on 2026-08-05 covering a total of 217,534 shares (93,229 and 124,305). Both grants were recorded at $0.00 (derivative awards/options) and were made in connection with his appointment as CEO. These are grants of options or option-like awards (no cash paid at grant).

Key Details

• Transaction date: 2026-08-05; Filing date (Form 4): 2026-08-07 (timely; within 2 calendar days).
• Grant amounts/prices: 93,229 and 124,305 shares @ $0.00 (derivative awards); total 217,534.
• Shares owned after transaction: not disclosed in the provided filing details.
• Footnotes:
  • F1: Award granted in connection with appointment as President & CEO.
  • F2: One award vests in four equal annual installments beginning 8/5/2027.
  • F3: The other award vests in two tranches tied to share-price performance (price hurdles sustained for 30 consecutive trading days) and requires two years' service (or earlier on a change in control); that award expires 10 years from grant.
• Transaction type: Award/Grant (code A) of derivative securities — not a cash purchase or sale.

Context
These are retention/compensation awards tied to Curtis’s CEO role rather than open-market purchases or sales. As derivative awards (options or performance-based awards), they do not create immediate proceeds; vesting and exercisability depend on time and/or stock-price performance. Such grants are common for new executives and are intended to align long-term incentives with shareholders.